Extracellular Vesicles and Ovarian Cancer

Extracellular vesicles (EVs) are a varied group of cell-derived, microscopic, fluid-filled pouches released from cells into neighboring microenvironments that quickly gaining recognition as potentially powerful tool against epithelial ovarian cancer (EOC). Recent studies show not only do EVs play an integral part in the development through intercellular communication, cell survival, and immune modulation but also may assist with early diagnosis improved treatments. EOC currently has few effective screening options for detection this disease; and, therefore, it is detected at advanced stage where more likely to recur, develop chemoresistance, ultimately become fatal. Newer research evaluated biomarkers novel targets treatment EOC. Moreover, possible immunomodulatory therapies directly target or make susceptible other modalities. Therefore, present exciting, promising approach which improve clinical outcome patients.